Skip to content

Curaevia

Active
Private limited companyfounded 2021active for 5 yearsLedebergstraat 67, 9050 Gent, BelgiumKBO/BCE: BE 0760.948.865
Summary

The annual accounts of Curaevia for financial year 2026 show a net loss of 83% of the equity at the start of that year. The 2026 annual accounts show equity of €4,865 and a net result of -€24,301. Equity is shrinking by about 16% per year across the filed financial years. Its solvency ranks better than 8% of 449 sector peers (NACE 62, financial year 2026). The company has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.7% (low).

History

Curaevia was incorporated on 7 January 2021 as a private limited company.1 The registered office was moved to Ledeberg in 2023.2 Total assets rose from €14,725 in 2022 to €206,530 in 2026.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 10-03-2023
  3. 3National Bank, annual accounts 2022 and 2026

Acts, filings and financial milestones

Next filing, financial year 2027, expected by 31-10-2027
2026
01-10
NBB filing Annual accounts filed
financial year 2026 · micro format
2025
02-10
NBB filing Annual accounts filed
financial year 2025 · micro format
24-07
Gazette deed Resignations: KRIYACONSULT BV (director) and Triple O Consulting & Investments BV (director)
Permanent representatives: Marc Van Uytven, Xavier Keters and Georges De Feu · Appointments: PHARMALEGAL BV (director) and Pieter Demoor (director)13 facts ▸
  • General meeting, 06-06-2025
  • Director resignation, KRIYACONSULT BV (director)
  • Director resignation, Triple O Consulting & Investments BV (director)
  • Permanent representative, Marc Van Uytven
  • Permanent representative, Xavier Keters
  • Director appointment, PHARMALEGAL BV (director)
  • Director appointment, Pieter Demoor (director)
  • Other provision, “aanvaarding mandaat en benoemingsverklaring, ondertekening van het onderhavige document” (deed in Dutch) (2 times)
  • Board meeting, 06-06-2025
  • Permanent representative, Georges De Feu
  • Board composition, Etienne Maeriën (director and managing director)
  • Board composition, PHARMALEGAL BV (director)
  • +1 further fact in this act
31-03
Financial Back to profitnet €485
Net result €485 after 3 loss-making years.
2024
16-10
NBB filing Annual accounts filed
financial year 2024 · micro format
2023
31-10
NBB filing Annual accounts filed
financial year 2023 · micro format
31-03
Financial Weakest financial yearnet -€83,741
Net result drops to -€83,741, the lowest in the series; recovery starts the following year.
10-03
Gazette deed Registered office · Resignations & appointments
Registered-office move · Power of attorney8 facts ▸
  • Board meeting, 05-01-2023
  • Registered-office move, Ledebergstraat 67,9050 Ledeberg
  • Power of attorney, Moore Finance & Tax BV
  • Power of attorney, Tanja De Naeyer
  • Power of attorney, Julje De Roy
  • Power of attorney, Dominique Jaminet
  • Power of attorney, Claudia Beurghs
  • Power of attorney, Irene Timmermans
2022
28-10
NBB filing Annual accounts filed
financial year 2022 · micro format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
2 of 5 deeds read
About the unread acts

Of the 5 Belgian Official Gazette deeds we know for this company, 2 have been read. The other 3 have not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.